Cashu
Pfizer Pursues Lyme Disease Vaccine Amid Clinical Trials and Regulatory Challenges
8 days ago
Stocks
Health Care
pfe
Pfizer
NYSE: PFE
+0.46 (+1.64%)
28.54
USD
At close at Apr 01, 20:33 UTC
Latest Pfizer News
benzinga.com
Pfizer, BioNTech Hit Pause On COVID Shot Trial As Enrollment Falls Flat
about 9 hours ago
benzinga.com
Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive
9 days ago
cnbc.com
Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss
10 days ago
benzinga.com
Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session
10 days ago
cnbc.com
How Cures is bringing rare disease stories to a national audience
13 days ago
cnbc.com
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
13 days ago
benzinga.com
Pfizer Combo Therapy Scores Major Win In Prostate Cancer Trial
13 days ago
prnewswire.com
Lucid Group Appoints Former Pfizer R&D Leader Rod MacKenzie, CMG, PhD, as Board Chair to Drive Next Phase of Global Growth and Innovation
15 days ago
benzinga.com
Federal Judge Flags Legal Flaws In RFK Jr.'s Vaccine Overhaul
16 days ago
cnbc.com
The conditions are just right for this dividend-paying pharma stock as it mounts a comeback
20 days ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.